Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California
American Journal of Health Promotion · 2025
DOI: 10.1177/08901171251315005 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health Promotion, 2025. Verfasst von Nicola Manalili und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology and Public Health, California Polytechnic State University San Luis Obispo, San Luis Obispo, CA, USA. Hauptthemen laut MEDLINE: Smoking Cessation, Tobacco Use Cessation Devices, Smoking Cessation Agents. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Teacher Scholar Mini Grant at California Polytechnic State University San Luis Obispo, William and Linda Frost Fund at California Polytechnic State University San Luis Obispo.
Abstract (Originalsprache)
Purpose
To examine associations between identified factors to accessing Food and Drug Administration-approved quit medication (FDAQM) and use among a sample of tobacco users.
Design
Cross-sectional, online survey.
Setting
County in Central California. Subjects Current adult tobacco users (n = 76). Measures Demographics self-reported likelihood of quitting in the next month, contacting a healthcare provider about quitting, time since last healthcare visit, provider asking about tobacco/nicotine use, provider advice to quit, provider FDAQM prescription and FDAQM use in the past year. Analysis Logistic regression.
Results
Those with a higher likelihood of quitting had a lower odds of FDAQM use (OR = 0.15, 95% CI = 0.03, 0.73) while those who had contacted a healthcare provider had a higher odds (OR = 15.39, 95% CI = 2.72, 87.05).
Conclusion
While the sample was limited, this research provides evidence in an understudied tobacco cessation area. More work is needed to understand the generalizability of these results and develop interventions that address these factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kinesiology and Public Health, California Polytechnic State University San Luis Obispo, San Luis Obispo, CA, USA.
- Tobacco Control Program, County of San Luis Obispo Health Agency, San Luis Obispo, CA, USA.
ORCID-Profile: Julia Alber, Adrienne Lent
Förderung
- Teacher Scholar Mini Grant at California Polytechnic State University San Luis Obispo
- William and Linda Frost Fund at California Polytechnic State University San Luis Obispo
Zitieren
APA
Manalili, N., Merzon, J., Alber, J., & Lent, A. (2025). Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California. American Journal of Health Promotion. https://doi.org/10.1177/08901171251315005
Vancouver
Manalili N, Merzon J, Alber J, Lent A. Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California. American Journal of Health Promotion. 2025. doi:10.1177/08901171251315005
BibTeX
@article{Manalili2025,
author = {Manalili, Nicola and Merzon, Jenelle and Alber, Julia and Lent, Adrienne},
title = {Factors Associated With FDA-Approved Quit Medication Use Among a Sample of Adult Tobacco Users in a County in Central California},
journal = {American Journal of Health Promotion},
year = {2025},
doi = {10.1177/08901171251315005}
}
EUVIMED